The value of measuring airway inflammation in the management of asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN80754328

Enrollment

Registered

2004-01-23

Start date

2000-06-19

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Respiratory Asthma

Interventions

1. Treatment of airways inflammation 2. Standard care

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 80 patients with asthma

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
Improved asthma control; control of airway inflammation; change in spirometry over one-year, severe exacerbations; total use of inhaled corticosteroids in each group; proportion of patients screened with a diagnosis of asthma without objective evidence.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026